0000-00-00 |
|
|
|
External link to document |
2017-05-15 |
129 |
Exhibit 1-12 |
U.S. Patent No. 7,235,576
U.S. Patent No. 7,235,576 (’576 patent) entitled “ω-Carboxyaryl….S. Patent No. 7,897,623 (“the ’623 patent”), U.S.
Patent No. 7,235,576 (“the ’576 patent”), U.S. Patent…,618,141 patent (“the ’141 patent”), the 7,897,623 patent (“the ’623 patent”), the 7,235,576
(“the …were filed with respect to U.S. Patent No.
7,235,576 and U.S. Patent No. 7,351,834. These Terminal Disclaimers…Interrogatory No. 3 as follows:
I. U.S. PATENT NOS. 7,235,576, 7,351,834, AND 7,897,623
Plaintiffs |
External link to document |
2017-07-10 |
152 |
|
. Regarding the Non-Infringement of U.S. Patent No. 8,618,141 [Confidential] filed by Mylan Pharmaceuticals…2015
26 October 2017
1:15-cv-00114
830 Patent
None
District Court, D. Delaware
|
External link to document |
2015-01-29 |
4 |
|
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,618,141 B2; 8,877,933 B2;. …2015
26 October 2017
1:15-cv-00114
830 Patent
None
District Court, D. Delaware
|
External link to document |
2016-03-28 |
56 |
|
8,618,141, 8,877,933, 7,897,623, 7,235,576, 7,351,834, and 8,841,330 filed by Bayer HealthCare LLC, Bayer…Asserted Patents and Accused Products; and (2) Patent File Histories of United States Patent Nos. 8,618,141…2015
26 October 2017
1:15-cv-00114
830 Patent
None
District Court, D. Delaware
|
External link to document |